Home > Pulmonology > NLC 2022 > Interstitial Lung Diseases (ILD) > No oral corticosteroids before a confirmed diagnosis of ILD

No oral corticosteroids before a confirmed diagnosis of ILD

Conference
NLC 2022
Doi
https://doi.org/10.55788/f2eea1d4
Data from a Finnish study assessing the pre-operative risk factors for transbronchial lung cryobiopsy (TBLC) complications in patients with interstitial lung disease (ILD) showed that patients should refrain from oral corticosteroids before a confirmed diagnosis. Also, severe cough should be considered before TBLC is considered. Not much is known about the pre-operative risk factors associated with TBLC complications. Therefore, a study evaluating the pre-operative risk factors of clinically relevant complications of TBLC in patients with ILD was initiated [1]. Apart from complication rates, the study also aimed to describe the Finnish TBLC procedure and to report the diagnostic yield of the procedure. Between January 2015 and December 2019, 100 patients (60 men) with a median age of 66.1 years were recruited from two Finnish hospitals (Kuopio University Hospital and Tampere University Hospital). The inclusion criteria consisted of a referral for a ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on